Neil Benson

Neil has 20 years’ experience of working in the pharmaceutical industry at SmithKline Beecham and Pfizer. He has held a number of senior leadership positions, most recently as Head of systems pharmacology at Pfizer, Sandwich. He was awarded the Pfizer Upjohn award for innovation in developing dose prediction methodology. He has extensive experience of using modelling and simulation to address questions of critical importance in drug discovery including; clinical dose prediction, optimal target identification and biomarker selection and has authored ~ 30 papers and patents. He is currently a Director at Xenologiq Ltd, a consultancy company focused on the productive application of PKPD and Systems Pharmacology in drug discovery. Educated at the University of East Anglia (UK) and the University of Lund (Sweden), Neil has a First class Honours degree and a PhD in enzymology.